ask="N/A"
ask_size="N/A"
average_daily_volume="2088140"
bid="N/A"
bid_size="N/A"
book_value="0.1680"
change="N/A"
change_from_200_day_moving_average="0.0260"
change_from_50_day_moving_average="0.0605"
change_from_52_week_high="-0.7498"
change_From_52_week_low="0.0882"
change_in_percent="N/A"
close="0.3702"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2040"
ebitda="-41.64M"
eps_estimate_current_year="-0.1300"
eps_estimate_next_quarter="-0.0300"
eps_estimate_next_year="-0.1100"
ex_dividend_date="N/A"
float_shares="229462000"
high="N/A"
high_52_weeks="1.1200"
last_trade_date="2/13/2017"
last_trade_price="0.3702"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="N/A"
low_52_weeks="0.2820"
market_capitalization="95.19M"
moving_average_200_day="0.3442"
moving_average_50_day="0.3097"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.2500"
open="N/A"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+7.5431%"
percent_change_from_50_day_moving_average="+19.5362%"
percent_change_from_52_week_high="-66.9464%"
percent_change_from_52_week_low="+31.2766%"
previous_close="0.3702"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.2036"
price_per_sales="1.7476"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.6200"
stock_exchange="NCM"
symbol="PPHM"
volume="0"
weeks_range_52="0.2820 - 1.1200"
